Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel […]
Public-Private Partnership Begins Clinical Trial in Sub-Saharan Africa.[NIH News]
As director of Beth Israel Deaconess’s Center for Virology and Vaccine Research, Barouch is behind a new vaccine that could stop the disease [HIV] in its tracks. [Boston Magazine article]
It takes a cocktail of drugs to treat HIV. It could take a cocktail of antibodies to prevent HIV as well, suggests a study in Science Translational Medicine by Boston-based researchers […]
By Carey Goldberg WBUR At a major international AIDS conference in Paris this week, researchers presented findings on a new HIV vaccine that look promising enough to launch a big clinical […]
By Meera Senthilingham
CNN, July 25th, 2017
A new study found zero transmission of HIV between more than 370 homosexual couples. Preventing new infections while a vaccine is developed is key to controlling the epidemic.
By Julia Belluz
Vox.com July 24th, 2017
The “mosaic vaccine” tackles the virus’s incredible genetic diversity.
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit